Back to Search
DOUGLAS HUHN, DMD
DMD
Dentist
NPI: 1114071628Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy.
PMID 17487734·Leuk Lymphoma·2007
8-other
Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
PMID 16502436·Cancer·2006
3-trial
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
PMID 12879428·Am J Hematol·2003
8-other
Malignant thymoma: current status of classification and multimodality treatment.
PMID 12601482·Ann Hematol·2003
6-review
New directions in the diagnosis and treatment of chronic lymphocytic leukaemia.
PMID 12699399·Drugs·2003
6-review
Lipid storage metabolism is limited by the prevailing low oxygen concentrations within developing seeds of oilseed rape.
PMID 14645733·Plant Physiol·2003
8-other
The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas.
PMID 12394253·Anticancer Drugs·2002
3-trial
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
PMID 12384407·Blood·2002
3-trial
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study.
PMID 11807632·Ann Hematol·2002
3-trial
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
PMID 11177563·Hum Gene Ther·2001
3-trial
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia.
PMID 11520778·Blood·2001
3-trial
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
PMID 11486402·Eur J Haematol Suppl·2001
8-other
Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses.
PMID 11309819·Cytometry·2001
8-other
Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization.
PMID 11195005·Ann Hematol·2000
4-observational
Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome.
PMID 11156214·Clin Cancer Res·2000
8-other
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agent.
PMID 11154978·Acta Haematol·2000
8-other
Increase in proliferation rate and normalization of TNF-alpha secretion by blockage of gene transfer-induced apoptosis in lymphocytes using low-dose cyclosporine A.
PMID 11129282·Cancer Gene Ther·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 SOUTH ORANGE AVE
ORLANDO, FL 32806 - Phone
- (407) 422-6281
Quick Facts
- NPI
- 1114071628
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile